CD80 expression promotes immune surveillance in Barrett’s metaplasia

Esophageal adenocarcinoma (EAC) is the final step of a pathway starting with esophageal reflux disease, Barrett’s metaplasia and Barrett’s dysplasia. Positive costimulatory ligands such as CD80 have been suggested to contribute to anti-tumor T-cell efficacy. Here we report for the first time the rol...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Scarpa, Melania, Fassan, Matteo, Kotsafti, Andromachi, Realdon, Stefano, Dall’Olmo, Luigi, Morbin, Tiziana, Cavallin, Francesco, Saadeh, Luca, Cagol, Matteo, Alfieri, Rita, Castoro, Carlo, Rugge, Massimo, Castagliuolo, Ignazio, Scarpa, Marco
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2019
Assuntos:
Brief Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6791427/
https://ncbi.nlm.nih.gov/pubmed/31646078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1636618
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados